CEN Biotech Inc (CENBF)
0.0033
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
CEN Biotech Net Income (Quarterly): -0.4009M for March 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | -0.4009M |
December 31, 2022 | -0.4875M |
September 30, 2022 | -0.4002M |
June 30, 2022 | -0.3483M |
March 31, 2022 | -0.2589M |
December 31, 2021 | -2.068M |
September 30, 2021 | -0.7189M |
June 30, 2021 | -15.49M |
March 31, 2021 | -0.623M |
December 31, 2020 | 19.14M |
September 30, 2020 | -1.926M |
June 30, 2020 | -1.660M |
March 31, 2020 | -1.300M |
December 31, 2019 | -1.229M |
September 30, 2019 | -1.332M |
June 30, 2019 | -1.851M |
March 31, 2019 | -1.243M |
December 31, 2018 | -3.161M |
Date | Value |
---|---|
September 30, 2018 | -1.389M |
June 30, 2018 | -1.660M |
March 31, 2018 | -1.321M |
December 31, 2017 | -10.60M |
September 30, 2017 | -1.205M |
June 30, 2017 | -1.224M |
March 31, 2017 | -1.048M |
December 31, 2016 | -6.436M |
September 30, 2016 | -0.5963M |
June 30, 2016 | -0.6264M |
March 31, 2016 | -0.5777M |
December 31, 2015 | -0.7615M |
September 30, 2015 | -0.5564M |
June 30, 2015 | -0.4368M |
March 31, 2015 | -0.6518M |
December 31, 2014 | -0.8564M |
September 30, 2014 | -0.4465M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-15.49M
Minimum
Jun 2021
19.14M
Maximum
Dec 2020
-0.6851M
Average
-0.9741M
Median
Net Income (Quarterly) Benchmarks
Rimrock Gold Corp | -0.0749M |
InMed Pharmaceuticals Inc | -1.478M |
Venus Concept Inc | -11.12M |
Juva Life Inc | -1.466M |
Lucy Scientific Discovery Inc | -2.620M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 0.0941M |
Total Expenses (Quarterly) | 0.478M |
EPS Diluted (Quarterly) | -0.021 |
Profit Margin (Quarterly) | -426.2% |